BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,749 | -1.5% | 79,000 | 0.0% | 0.00% | – |
| Q2 2023 | $77,902 | -3.9% | 79,000 | 0.0% | 0.00% | – |
| Q1 2023 | $81,050 | -86.8% | 79,000 | -86.3% | 0.00% | -100.0% |
| Q4 2022 | $612,712 | -1.2% | 575,000 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $620,000 | -9.4% | 625,000 | -9.3% | 0.00% | 0.0% |
| Q2 2022 | $684,000 | -31.7% | 689,000 | -30.9% | 0.00% | -50.0% |
| Q1 2022 | $1,002,000 | -21.7% | 997,000 | -17.9% | 0.00% | 0.0% |
| Q4 2021 | $1,280,000 | +48.3% | 1,214,000 | +45.2% | 0.00% | +100.0% |
| Q3 2021 | $863,000 | +9.4% | 836,000 | +10.6% | 0.00% | 0.0% |
| Q2 2021 | $789,000 | -64.3% | 756,000 | -65.6% | 0.00% | -75.0% |
| Q4 2017 | $2,207,000 | +81.3% | 2,200,000 | +83.3% | 0.00% | +100.0% |
| Q3 2017 | $1,217,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |